Ketamine-Derived Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
US Weekly on MSN9d
What Celebrities and Doctors Have Said About Ketamine Use: Chrissy Teigen, Matthew Perry, MoreCelebrities like Chrissy Teigen and Matthew Perry have been open about using ketamine for their mental health – here's what ...
Esketamine, the chemical name for Spravato, is a chemical mirror image of anesthetic ketamine, which is also abused as a recreational party drug and goes by the street nickname "Special K".
Inquirer on MSN5d
Ketamine a lifeline for patients with severe depressionKetamine, the controlled drug best known as a horse tranquilliser, has in the last four years become a boon to scores of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback